In clinical practice, the ankle-brachial index (ABI) is regarded as a reliable, non-invasive measure of the presence and severity of PAD. [19] [20] [21] The treadmill test is also a non-invasive diagnostic tool commonly used in clinical practice to evaluate the existence and severity of PAD, as well as being a functional test of walking impairment. 20, 22 The angiographic score is used as an invasive diagnostic tool, and provides information about the site and severity of the arterial lesions in patients with PAD, but gives no information about the degree of functional impairment. 23 Only limited data exist with regard to associations between biomarkers of atherosclerosis and the extent and severity of PAD. In the present cross-sectional study of patients with verified PAD, we wanted to examine whether or not there were any relationships between some circulating markers of vascular inflammation and the functional and anatomic measures used in the diagnosis of PAD, assessed as ABI, treadmill walking distances and angiographic score.
Materials and methods

Study population
The study population comprised 127 patients (81 males and 46 females), ranging from 45 to 79 years. All patients had clinically and angiographically verified PAD, and mild to moderate symptoms of IC. The angiography was performed in order to assess the technical possibility to perform percutaneous transluminal angioplasty (PTA). The patients were recruited consecutively during a 2-year period from November 2000 at the Department of Vascular Surgery, Aker University Hospital, Oslo, Norway.
The study population was referred to the outpatient clinic with IC as the tentative diagnosis. In the course of recruitment to the study, localization and severity of the arterial circulatory disorder in the legs was determined by recording the patient's history as well as accomplishing a clinical and diagnostic examination. This examination included Doppler measurement and calculation of the ankle-brachial pressure index (ABI) for determination of the hemodynamic PAD severity, a treadmill test to assess the functional impairment of PAD, and angiography to determine the precise extent and localization of peripheral limb atherosclerosis. Fasting blood samples were drawn for determination of selected soluble cell adhesion molecules, cytokines and chemokines.
The patients were eligible to enter the study if they were Ͻ80 years old, had suffered from symptomatic IC for a minimum of 3 months prior to evaluation, had an ABI Ͻ 0.9 without rest pain and/or ulcers, had a subjective pain-free walking distance Ͻ400 m, were able to exercise on a treadmill, had no previous vascular or endovascular surgery, did not suffer from diabetic ulcer or renal insufficiency (defined as s-creatinine Ͼ150 mol/l) and were not on oral anticoagulant medication, or suffering from a physical or mental disorder expecting to impede compliance.
Approval was given from the regional ethical committee, and all patients gave written, informed consent to participate. All examinations were performed at inclusion into the study.
Ankle-brachial pressure index measurement
There are no specific guidelines with recommendations on how the lower extremity arterial pressures should be used to calculate the ABI in clinical settings. We chose to measure the ABI at rest only, by using the following established method. 24 After a 5-minute rest period in a supine position, appropriately sized blood pressure cuffs were placed over each brachial artery and above each malleolus. A hand-held Doppler probe (Parks model 811; Parks Medical Electronics Inc, Aloha, OR, USA) was used to measure systolic blood pressures in the brachial arteries, the anterior tibial arteries and the posterior tibial arteries. Each pressure was measured twice, and the average value was used in subsequent analysis. The average brachial pressure in the arm with the highest systolic pressure was used. Hence, the ABI was calculated for both lower limbs by division of the highest systolic ankle pressure in each limb by the value of the highest brachial artery pressure. The ABI obtained from the patient's primary symptomatic side was used for subsequent analysis. In the four cases where the two sides were subjectively and objectively indiscriminate from one another, the right leg was referred to as the primary symptomatic leg.
Treadmill
The treadmill test was performed twice (the first one to familiarize the patients with the treadmill, and the second one for use in subsequent analyses), in order to get an objective measure of the pain-free and maximum walking distances. A standard treadmill test (Treadmill Proform, Icon Health & Fitness, Logan, USA) with a constant speed of 3 km/h and a fixed grade of 10°was chosen. The patients indicated when the onset of claudication pain occurred (pain-free walking distance) and then proceeded to walk up to absolute claudication distance (maximum walking distance). The pain-free and maximum walking distances were recorded for the primary limiting side up to a maximum of 600 m (12 minutes), even though the patients in some cases were able to walk further. In these cases, the maximum walking distance was equaled to 600 m.
Angiography
All patients underwent standard outflow imaging of the aorta and lower extremities with a standard technique with puncture of the common femoral artery and digital subtraction (Siemens Multistar TOP, Germany).
All examinations were performed by using 4 F straight catheters with side holes (Cordis, The Netherlands). The first series were run with the catheter placed under fluoroscopic control in the aorta at the origin of the renal arteries. In the remaining series, the catheter was placed in the distal aorta at the level of the fourth lumbar vertebra. Non-ionic contrast material (75-100 ml Visipaque 270 mg iodine/ml; Amersham, Norway) was injected by means of an automated pump at a rate of 15 ml per second. The examination consisted of anteroposterior projections in all patients, and 30°left and right anterior-oblique images in the pelvis. A standard bolus-chase technique was used to evaluate the infrainguinal arteries.
Image evaluation
The following arterial segments (distal aorta plus 10 segments on each side) were assessed: common iliac artery, external iliac artery, common femoral artery, profunda femoral artery, superficial femoral artery, popliteal artery, tibio-peroneal trunk, anterior tibial artery, posterior tibial artery and fibular artery. The angiograms were read by an experienced vascular interventional radiologist, and the findings were considered to be the standard for diagnosis in all cases. The arterial segments were graded as having less than 50% stenosis, equal to or greater than 50% stenosis or as being occluded, hence the scoring system used is a modification of the system introduced by Meaney. 25 A score was given to the area with the greatest narrowing in each segment. The following scores were used: 0 ϭ normal, 1 ϭ stenosis Ͻ50% (luminal irregularities, insignificant stenosis), 2 ϭ stenosis Ͼ50% (significant stenosis), 3 ϭ occlusion. The different scores for each of the 21 segments were then added up to give the angiographic score for each patient, 63 being the maximal score.
Laboratory methods
Venous blood samples were drawn between 8 am and 9 am after an overnight fasting on the same day as the angiography and treadmill walking test were performed. Serum was prepared within 1 hour by centrifugation 2000 ϫ g at room temperature for 15 minutes. Citrated and EDTA blood were collected and stored on ice until platelet-poor plasma was obtained within 30 minutes by centrifugation 2000 ϫ g for 20 minutes. All samples were kept frozen at Ϫ70 °C until analyzed, except from lipoprotein, glucose and HbA1c, which were analyzed by conventional enzymatic methods. Vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, P-selectin, tumor necrosis factor ␣ (TNF␣), interleukin-6 (IL-6), interleukin-10 (IL-10), CD40 ligand (CD40L) and monocyte chemoattractant protein-1 (MCP-1) were analysed with commercial ELISA methods (R&D System, Abingdon, Oxon, UK) as was also high-sensitivity CRP (DRG Diagnostics, DRG Instruments GmbH, Germany). P-selectin was measured in citrated plasma and CD40L in EDTA plasma, otherwise serum was used. The inter-assay coefficients of variation were for VCAM-1 5.2%, ICAM-1 4.8%, E-selectin 5.3%, P-selectin 7.2%, TNF␣ 8.5%, IL-6 10.7%, IL-10 6.2%, CD40L 9.7%, MCP-1 9.2% and CRP Ͻ5%.
Statistical analysis
Results were analyzed statistically using the SPSS software package for Windows, version 12 (SPSS Inc, Chicago, IL, USA). Clinical and demographic data are presented as mean (SEM) or proportions. Spearman coefficient of correlation was calculated to evaluate relationships between different variables. Multiple linear regression models were performed to adjust for relevant co-variates (age, smoking, diabetes mellitus, treated hypertension, homocysteine and untreated hypercholesterolemia (defined as s-total cholesterol Ͼ5 mmol/l and/or s-low density lipoprotein (LDL) Ͼ3 mmol/l)) and also for use of statin and aspirin. When evaluating the independent relationship between biochemical variables and the anatomic and functional measures, angioscore, ABI and treadmill maximum walking distance were set as dependent variables in separate models. Skewed variables were log-transformed before being entered into the regression models. For group comparisons the Mann-Whitney rank sum test was used as several variables were skewly distributed. A two-tailed value of p Ͻ 0.05 was considered statistically significant.
Results
Patient history and clinical information as well as the measured inflammatory variables recorded are presented in Table 1 . At the time of inclusion, 67% of the patients were current smokers, 24% had smoked previously, and 9% had never been smokers. Treatment with antidiabetic agents was used to define diabetes mellitus, and was recorded in 13% of the population. Coronary heart disease was defined as angina pectoris and/or a previous myocardial infarction documented by ST-elevation in ECG recordings and/or rise in cardiac enzymes. Untreated hypercholesterolemia at the time of examination was recorded in 71% of the patients, whereas only 21% were treated with statins. The patients had a median duration time of symptoms 12 months before examination, indicating that many had suffered from their walking impairments for a long time.
Pain-free walking distance was highly correlated with the maximum walking distance (p Ͻ 0.001), as shown in Table 2 , and further analysis therefore includes only the maximum walking distance. The angiographic score was inversely correlated with both ABI (p ϭ 0.007) and maximum walking distance all variables) ( Table 3) , whereas ICAM-1 and IL-6 were significantly inversely correlated to the maximum treadmill walking distance (p Ͻ 0.05). None of the inflammatory markers correlated with the ABI. In multiple linear regression analyses, adjusted for the relevant co-variates, MCP-1 and CD40L were still independently associated with the angiographic score, and IL-6 with the maximum treadmill walking distance (p Ͻ 0.01 for all) ( Table 4 ). TNF␣ and IL-6 were no longer significantly correlated to the angiographic score, and the correlation between ICAM-1 and the maximum treadmill walking distance lost significance.
Discussion
In the present study, the main findings were that the levels of the vascular inflammatory markers MCP-1 and CD40L were associated with the angiographic score, and IL-6 was inversely associated with the maximum treadmill walking distance in our population of patients with PAD. These data indicate that the inflammatory process of atherosclerosis is associated with the anatomical as well as the functional severity of PAD.
None of the inflammatory markers correlated with the ABI, which is in accordance with the findings of McDermott et al 26 and Santos et al, 27 who both reported an association between ABI and CRP, but this disappeared after adjusting for conventional risk factors. Folsom et al, 28 however, noted in a large crosssectional study a weak inverse correlation between CRP and ABI in men, independent of other risk factors.
There are different reports with regard to comparisons of the anatomical and physiological diagnostic measures of PAD. We found the angiographic score to be inversely correlated with both ABI and maximum walking distance. There was no correlation between ABI and maximum treadmill walking distance, which might be explained by the lack of healthy people in the study. The fairly homogenous ABIs may be reducing our ability to find substantial correlations and could explain the differences between studies. The peripheral circulation at rest is, nevertheless, physiologically quite different from the circulation during exercise. (p ϭ 0.003), whereas there was no correlation between ABI and maximum walking distance. TNF␣, IL-6, MCP-1 and CD40L were significantly correlated with the angiographic score (p Ͻ 0.05 for Previous reports confirm the correlation between angiography and ABI, [29] [30] [31] although conflicting results exist as well. 32 The lack of correlation between ABI and maximum treadmill walking distance in our study population is not in accordance with the findings of Müller-Bühl et al. 33 In fact, studies have not unanimously reported relations between the anatomical and physiological diagnostic measures of PAD. 26, 31, 33 One suggestion might be that these measures reflect different aspects of atherosclerosis and are therefore not easily compared.
Due to the strict inclusion criteria for participation in the present study, the population consisted of a homogenous group of patients in an early stage of disease compared with patients in many other studies. This is reflected in the relatively low number of diabetes mellitus patients recorded (13%) in the population. None of the patients were on oral anticoagulant medication, had previous endovascular or vascular surgery, or had signs of critical ischemia, defined as rest pain and/or ulcers. This might explain why not all the inflammatory markers correlated with the anatomical and functional measures in this study. The different markers measured are probably also reflecting different aspects of atherosclerosis. 5, 8 Measurement of the ABI is a practical tool in clinical practice, but ABI measurements cannot be used to expand the understanding of the pathophysiological mechanisms of the disease.
Although association between inflammation and atherosclerosis is well recognized, most studies have focused on coronary heart disease. Limited data exist on associations between inflammatory markers and peripheral atherosclerosis. We could demonstrate a correlation between the treadmill walking distance and ICAM-1, indicating increased endothelial activation in our patients. However, this association was not independent of other related risk factors, which might result from the fact that our study population consist of patients with a less severe degree of PAD, still being in an early stage of their disease. We found a significant association between the levels of MCP-1 and angiographic score. Chemokines like MCP-1 are small proteins produced by and released from a broad spectrum of cells, 34 and represent a group of chemotactic cytokines that induce cellular locomotion. 35 The primary biologic function of MCP-1 appears to involve recruitment of mononuclear cells to the sites of inflammation, hence inducing further inflammation and also procoagulant activity that may enhance thrombosis in atherosclerotic plaques. 36, 37 MCP-1 seems therefore to play a crucial role in the earliest stages of atherosclerosis. Elevated plasma levels of MCP-1 have also recently been related to increased risk of death and myocardial infarction in patients with acute coronary syndromes. 38 CD40, a membrane protein of the TNF receptor family, and CD40L, a member of the cytokine TNF family, are co-expressed by all of the major cellular players in atherosclerosis. 39 CD40L is mainly derived from activated platelets, and elevated circulating levels seem to indicate a significantly increased risk of cardiovascular death. 40 Increased plasma levels of CD40L have also been observed in patients with moderate hypercholesterolemia and diabetes mellitus. 41, 42 The clinical association with the CD40/CD40L complex therefore suggests involvement in the whole process of atherosclerosis, from early stages of inflammation to late severe thrombotic complications. 6 Thus, the association between CD40L and the extent of PAD observed in our study is interesting and fits this picture. The results may also indicate that activated platelets are of special importance in the progression of the disease.
Our findings of IL-6 to be independently related to the treadmill walking distance also indicate that patients with PAD have a generalized increased inflammation. IL-6 is a well-known stimulator of acute phase proteins and has also been recognized as a mediator of cardiovascular risk 43 IL-6 is released by a variety of cells and tissues upon different stimuli, 43, 44 and is argued to reflect a process of general inflammation, thus playing a key role in the whole process of atherosclerosis.
Aspirin is known to, and statins are supposed to, possess anti-inflammatory properties. However, there were no differences in the measured variables either between patients with or without aspirin treatment, or with regard to use of statins or not in our study population. Use of these medications was nevertheless included in the multiple regression analysis, without influencing the result.
There are different reports regarding angiographic scoring systems other than the one we used in our study, described by Bollinger et al. 45 and Scott et al. 46 However, to our knowledge, no reports have demonstrated any angiographic scoring system better suited to serve the purpose of the present study than the one we used. We also chose to use a single-stage treadmill with a fixed grade of 10°instead of a progressive, multiple-stage treadmill in our investigations. Conflicting opinions exist, however, concerning which type of treadmill provides the best assessment of PAD severity. 47 In conclusion, our results demonstrate that the inflammatory variables MCP-1, CD40L and IL-6 are all independently related to the extent of atherosclerosis in patients with PAD, indicating vascular inflammation to be implicated in PAD. Additional knowledge on the role of inflammation in PAD may be of importance in the future diagnosis, treatment and prognosis of patients with the disease.
